CASI Pharmaceuticals Inc (CASIF) – Company Profile and SWOT Analysis

CASI Pharmaceuticals Inc (CASIF) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company that focuses on the development and commercialization of therapies for treating cancer and other unmet medical needs. The company’s major products include EVOMELA (melphalan for injection), an intravenous formulation for the treatment of multiple myeloma, and FOLOTYN (pralatrexate), an inhibitor of dihydrofolate reductase, indicated for treating individuals with relapsed or refractory peripheral T-cell lymphoma (PTCL). These products are primarily used in the treatment of hematological malignancies and are targeted at patients requiring stem cell transplantation or treatment for conditions like multiple myeloma and peripheral T-cell lymphoma. CASI collaborates with partners such as Juventas and BioInvent for product development and commercialization. The company operates its subsidiaries in the US and China and a research and development center in Beijing, China. CASI is headquartered in Beijing, China.

Scope

• Detailed information on CASI Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting CASI Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of CASI Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about CASI Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess CASI Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on CASI Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda Pharmaceutical Co Ltd

Shenzhen Chipscreen Biosciences Co Ltd

KeyMed Biosciences Inc

Biogen Inc

Timberlyne Therapeutics Inc

Sichuan Huiyu Pharmaceutical Co Ltd

Genentech Inc

CSPC Ouyi Pharmaceutical Co Ltd

Table of Contents